Is Viridian Therapeutics Inc halal to invest in?

As of July 2026, Viridian Therapeutics Inc 1S1.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Viridian Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Viridian Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Viridian Therapeutics Inc?

Muslim investors may consider investing in Viridian Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Viridian Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Viridian Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Viridian Therapeutics Inc updated?

The Shariah compliance status of Viridian Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Viridian Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Viridian Therapeutics Inc?

You can check the latest Shariah compliance status of Viridian Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Viridian Therapeutics Inc 1S1.BE

Last Updated: Dec 17, 12:00 AM·BE

1S1.BE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Viridian Therapeutics Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Viridian Therapeutics Inc. Stock Analysis 1S1.BE

Germany Health Care Mid Cap Report: Q1, 2026

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. The company is headquartered in Waltham, Massachusetts and currently employs 143 full-time employees. The company went IPO on 2014-06-18. The firm is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The firm is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of veligrotug in patients with active and chronic TED. The company is also conducting two global Phase 3 clinical trials, REVEAL-1 and REVEAL-2, to evaluate the efficacy and safety of VRDN-003 in patients. Its advanced program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED. In addition to its TED portfolio, the Company is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.

Key Statistics of Viridian Therapeutics Inc (1S1.BE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€27.31€28.24

Today's Open

€28.07

Volume

P/E Ratio (TTM)

Financial Metrics & Statements of Viridian Therapeutics Inc (1S1.BE)

Super Investors Invested in Viridian Therapeutics Inc (1S1.BE)

FAQ's for Viridian Therapeutics Inc (1S1.BE)

As of July 2026, Viridian Therapeutics Inc 1S1.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Viridian Therapeutics Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Viridian Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Viridian Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Viridian Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Viridian Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.